Human Papillomavirus (HPV) Vaccine Market
Pharmaceuticals

Human Papillomavirus (HPV) Vaccine Market is to rise at a CAGR of 5.0% from 2022 to 2028.

Human papillomaviruses is a diverse group of DNA-based viruses that infect the mucous and skin membranes of humans and various animals. More than 100 different types of human papillomavirus have been characterized. Increasing prevalence of various cancers caused by human papillomavirus is expected to drive the market during the forecast period. According to the Centers […]